Ensysce Biosciences Stock Investor Sentiment

ENSC Stock  USD 5.34  0.05  0.93%   
About 62% of Ensysce Biosciences' investor base is looking to short. The analysis of the overall investor sentiment regarding Ensysce Biosciences suggests that many traders are alarmed. The current market sentiment, together with Ensysce Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ensysce Biosciences stock news signals to limit their universe of possible portfolio assets.
  

Ensysce Biosciences Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Ensysce Biosciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
51.6%
50.5%
58.8%
57.6%
59.1%
51.7%
52.2%
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over a week ago at gurufocus.com         
Anson Funds Management LPs Strategic Acquisition in Ensysce Biosciences Inc
Gurufocus Stories at Macroaxis
over two weeks ago at news.google.com         
How To Trade - Stock Traders Daily
Google News at Macroaxis
over two weeks ago at newswire.com         
Ensysce Biosciences Reports Continued Positive Progress in Groundbreaking Trial on PF614-MPAR, Comme...
news
over three weeks ago at finance.yahoo.com         
When Can We Expect A Profit From Ensysce Biosciences, Inc.?
Yahoo News
over three weeks ago at www.macroaxis.com         
Acquisition by Gower Bob G of 7919026 shares of Ensysce Biosciences subject to Rule 16b-3
Macroaxis News
over three weeks ago at thelincolnianonline.com         
Short Interest in Ensysce Biosciences, Inc. Grows By 85.7
news
over a month ago at finance.yahoo.com         
ENSC Continues to Announce Potential Life-Changing Results
Yahoo News
over a month ago at newswire.com         
Ensysce Biosciences Announces Positive Interim Data for Breakthrough Therapy PF614-MPAR
news
over a month ago at www.macroaxis.com         
Acquisition by Wright Richard Chester of 49975 shares of Ensysce Biosciences subject to Rule 16b-3
Macroaxis News
over a month ago at newswire.com         
Ensysce Biosciences Issues Annual Shareholder Letter
news
over two months ago at finance.yahoo.com         
Ensysce Biosciences Regains Full Compliance with Nasdaq
Yahoo News
over two months ago at seekingalpha.com         
Ensysce Biosciences regains compliance from Nasdaq
seekingalpha News
over two months ago at www.macroaxis.com         
Acquisition by Martin Steven Robert of 15000 shares of Ensysce Biosciences subject to Rule 16b-3
Macroaxis News
over two months ago at thelincolnianonline.com         
Ensysce Biosciences, Inc. Sees Significant Drop in Short Interest
news
over two months ago at finance.yahoo.com         
Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
Yahoo News
Far too much social signal, news, headlines, and media speculation about Ensysce Biosciences that are available to investors today. That information is available publicly through Ensysce media outlets and privately through word of mouth or via Ensysce internal channels. However, regardless of the origin, that massive amount of Ensysce data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ensysce Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ensysce Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ensysce Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ensysce Biosciences alpha.

Ensysce Biosciences Performance against Dow Jones

 Price Growth (%)  
JavaScript chart by amCharts 3.21.151234567Dec2025Feb -40-30-20-100
JavaScript chart by amCharts 3.21.15Ensysce Biosciences Ensysce Biosciences Dividend Benchmark Dow Jones Industrial
       Timeline  
1
Disposition of 359869 shares by Silvers Daniel B. of Ensysce Biosciences subject to Rule 16b-3
11/29/2024
2
Acquisition by Martin Steven Robert of 15000 shares of Ensysce Biosciences subject to Rule 16b-3
12/13/2024
3
Ensysce Biosciences Issues Annual Shareholder Letter
01/08/2025
4
Acquisition by Wright Richard Chester of 49975 shares of Ensysce Biosciences subject to Rule 16b-3
01/17/2025
5
ENSC Continues to Announce Potential Life-Changing Results
01/22/2025
6
Acquisition by Gower Bob G of 7919026 shares of Ensysce Biosciences subject to Rule 16b-3
01/31/2025
7
When Can We Expect A Profit From Ensysce Biosciences, Inc.
02/04/2025

Complementary Tools for Ensysce Stock analysis

When running Ensysce Biosciences' price analysis, check to measure Ensysce Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ensysce Biosciences is operating at the current time. Most of Ensysce Biosciences' value examination focuses on studying past and present price action to predict the probability of Ensysce Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ensysce Biosciences' price. Additionally, you may evaluate how the addition of Ensysce Biosciences to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Commodity Directory
Find actively traded commodities issued by global exchanges
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
News Freq…Investor S…